
Toxicology
Found 13580 products of "Toxicology"
Linezolid Dimer
CAS:Controlled ProductFormula:C30H35F2N5O7Color and Shape:NeatMolecular weight:615.62methyl (33R,35S,91R,92R,5S)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate
CAS:Controlled ProductFormula:C30H36F2N4O7Color and Shape:NeatMolecular weight:602.626α-(1-Chlorocyclopropyl)-α-[(2-chloro-5-hydroxyphenyl)methyl]-1H-1,2,4-triazole-1-ethanol (Prothioconazole)
CAS:Controlled ProductFormula:C14H15Cl2N3O2Color and Shape:NeatMolecular weight:328.1942-Iodo-4-(1-methylethyl)-6-(trifluoromethyl)pyrimidine
CAS:Controlled ProductApplications 2-Iodo-4-(1-methylethyl)-6-(trifluoromethyl)pyrimidine is a pyrimidine compound, generally used in the synthesis of pharmaceutical compounds, it may be used in the synthesis of cycloindoles for the treatment of hepatitis C.
Formula:C8H8F3IN2Color and Shape:NeatMolecular weight:316.062Sofosbuvir 3',5'-Bis-(S)-phosphate
CAS:Controlled ProductApplications Sofosbuvir 3',5'-Bis-(S)-phosphate is an impurity of PSI-7977 (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.
References Lam, A.M.,et al.: Antimicrob. Agents. Chemotherapy., 56, 3359 (2012); Lam, A.M., et al.: J. Virol., 85, 12334 (2011); Sofia, M.J., et al.: J. Medn. Chem., 53, 7202 (2010)Formula:C34H45FN4O13P2Color and Shape:NeatMolecular weight:798.686(1R,4S)-3-Oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid 1,1-Dimethylethyl Ester
CAS:Controlled ProductApplications (1R,4S)-3-Oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid 1,1-Dimethylethyl Ester is an intermediate in synthesizing ent-Abacavir (Abacavir EP Impurity A) (A105015), an enatiomer of Abacavir (A105000). Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor and an anti-HIV drug used to treat HIV infection (1). Intracellular enzymes convert Abacavir to its active form, carbovir-triphosphate (CBV-TP), which then selectively inhibits HIV reverse transcriptase by incorporating into viral DNA (2). Abacavir is metabolized in the liver by uridine diphosphate glucuronyltransferase and alcohol dehydrogenase resulting in inactive glucuronide and carboxylate metabolites, respectively.
Formula:C11H15NO3Color and Shape:NeatMolecular weight:209.2425-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-[N-(6-aminohexyl)carbamate]-D-glycero-D-galacto-Non-2-enonic Acid Bis(trifluoroacetate)
CAS:Controlled ProductFormula:C19H34N6O8•2(C2HF3O2)Color and Shape:NeatMolecular weight:588.236685-Amino-1-N-methylindole
CAS:Controlled ProductApplications 5-Amino-1-N-methylindole (CAS# 102308-97-4) is an indole derivative and building block, used in the copper-catalyzed synthesis of sulfonamides.
References Chen, Y.; et al.: J. Am. Chem. Soc., 140, 8781 (2018);Formula:C9H10N2Color and Shape:NeatMolecular weight:146.182-Methoxy-3-pyridinesulfonyl Chloride
CAS:Controlled ProductApplications 2-methoxy-3-pyridinesulfonyl chloride is patented as a reactant used to prepare erythromycin macrolide antibiotics as antibacterial and antiprotozoal agents.
Formula:C6H6ClNO3SColor and Shape:NeatMolecular weight:207.635Lopinavir 4-O-Tetrahydropyrimidin-2-(1H)-onyl-L-valinate
Controlled ProductFormula:C46H62N6O7Color and Shape:NeatMolecular weight:811.024-Amino-N-((2S,3R)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide Dihydrochloride
CAS:Controlled ProductFormula:C20H31Cl2N3O3SColor and Shape:NeatMolecular weight:464.45U 75875
CAS:Controlled ProductApplications U 75875, is a peptidomimetic inhibitor, that inhibits HIV-1 gag-pol protein. In human peripheral blood mononuclear cells and in a continuous cell line, U-75875 completely blocked HIV replication, so it can be used as therapeutic potential of protease inhibitors for treatment of HIV infection.
References Ashorn, P., et al.: Proceedings of the National Academy of Sciences of the United States of America, 87, 7472 (1990);Formula:C45H61N7O7Color and Shape:NeatMolecular weight:812.009N-(Trimethylsilyl)methanesulfonamide
CAS:Controlled ProductFormula:C4H13NO2SSiColor and Shape:NeatMolecular weight:167.302Dolutegravir RR Isomer
CAS:Controlled ProductFormula:C20H19F2N3O5Color and Shape:NeatMolecular weight:419.38((1R,4S)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl Formate
Controlled ProductFormula:C12H12ClN5O2Color and Shape:NeatMolecular weight:293.7094-Oxo-5-(3-phenyl-2-propen-1-ylidene)-2-thioxo-3-thiazolidineacetic Acid
CAS:Controlled ProductFormula:C14H11NO3S2Color and Shape:NeatMolecular weight:305.372(3R,5S)Posaconazole
CAS:Controlled ProductFormula:C37H42F2N8O4Color and Shape:NeatMolecular weight:700.77712b-Deoxycholic Acid Methyl Ester 3a-Benzoate
Controlled ProductApplications 12β-Deoxycholic Acid Methyl Ester 3α-Benzoate is an intermediate in the synthesis of 3α,12β-Dihydroxycholanoic Acid is a bile acid that may decrease of the toxic effects of deoxycholic acid on lipid peroxidn.
References Hino, A., et. al.: J. Biochem., 129, 683 (2001)Formula:C32H46O5Color and Shape:NeatMolecular weight:510.7
